Virginia Retirement Systems
CRL icon

Virginia Retirement Systems’s Charles River Laboratories CRL Stock Holding History

Virginia Retirement Systems’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.51M Sell
11,900
-5,100
-30% -$1.34M 0.02% 368
2026
Q2 		$3.86M Buy
17,000
+3,300
+24% +$588K 0.02% 373
2026
Q1 		$2.36M Buy
13,700
+500
+4% +$92.7K 0.02% 401
2025
Q4 		$2.63M Sell
13,200
-800
-6% -$145K 0.02% 367
2025
Q3 		$2.19M Buy
14,000
+1,500
+12% +$238K 0.01% 407
2025
Q2 		$1.9M Buy
12,500
+4,600
+58% +$613K 0.01% 416
2025
Q1 		$1.19M Buy
+7,900
New +$1.32M 0.01% 520
2021
Q2 		– Sell
-9,800
Closed -$2.84M – 1040
2021
Q1 		$2.84M Sell
9,800
-500
-5% -$139K 0.03% 364
2020
Q4 		$2.57M Buy
10,300
+1,300
+14% +$310K 0.03% 358
2020
Q3 		$2.04M Buy
9,000
+500
+6% +$104K 0.02% 370
2020
Q2 		$1.48M Sell
8,500
-6,300
-43% -$1.01M 0.02% 458
2020
Q1 		$1.87M Sell
14,800
-1,500
-9% -$225K 0.03% 396
2019
Q4 		$2.49M Buy
16,300
+1,400
+9% +$194K 0.03% 395
2019
Q3 		$1.97M Buy
14,900
+4,000
+37% +$536K 0.02% 435
2019
Q2 		$1.55M Hold
10,900
– – 0.02% 512
2019
Q1 		$1.58M Hold
10,900
– – 0.02% 505
2018
Q4 		$1.23M Buy
10,900
+2,600
+31% +$326K 0.02% 550
2018
Q3 		$1.12M Buy
8,300
+100
+1% +$12.3K 0.01% 676
2018
Q2 		$921K Buy
+8,200
New +$886K 0.01% 704
2018
Q1 		– Sell
-2,800
Closed -$306K – 998
2017
Q4 		$306K Sell
2,800
-17,200
-86% -$1.87M ﹤0.01% 891
2017
Q3 		$2.16M Sell
20,000
-4,100
-17% -$421K 0.03% 481
2017
Q2 		$2.44M Sell
24,100
-400
-2% -$36.8K 0.03% 424
2017
Q1 		$2.2M Buy
24,500
+16,100
+192% +$1.37M 0.03% 448
2016
Q4 		$640K Buy
8,400
+3,800
+83% +$289K 0.01% 691
2016
Q3 		$383K Buy
+4,600
New +$386K 0.01% 762

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ariel Investments
Ariel Investments Chicago, Illinois $9.6B AUM 22.21% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $25.4B AUM 35.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Virginia Retirement Systems's CRL Position: Q3 2026 in Review

Virginia Retirement Systems reduced its Charles River Laboratories (CRL) stake by 30% in Q3 2026, selling an estimated $1.34M and leaving 11,900 shares worth $3.51M. The position accounts for 0.02% of the portfolio, ranked #368.

Virginia Retirement Systems first reported a position in CRL in Q3 2016 and has held it in 25 quarters since. The position peaked at $3.86M in Q2 2026. 515 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Virginia Retirement Systems held 11,900 shares of Charles River Laboratories worth $3.51M as of Q3 2026.
  • Virginia Retirement Systems sold 5,100 Charles River Laboratories shares in Q3 2026, an estimated $1.34M.
  • Charles River Laboratories made up 0.02% of Virginia Retirement Systems's portfolio in Q3 2026, its #368 holding.
  • Virginia Retirement Systems first reported a position in Charles River Laboratories in Q3 2016 and has held it in 25 quarters since.
  • Virginia Retirement Systems's Charles River Laboratories position peaked at $3.86M in Q2 2026.
  • 515 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Virginia Retirement Systems's 13F filing for Q3 2026, filed 28 Oct 2026.